2020
DOI: 10.3389/fnins.2020.00616
|View full text |Cite
|
Sign up to set email alerts
|

Recent Preclinical Insights Into the Treatment of Chronic Traumatic Encephalopathy

Abstract: Chronic traumatic encephalopathy (CTE) is a neurodegenerative condition associated with significant mortality and morbidity. The central pathophysiological mechanisms by which repetitive cranial injury results in the neurodegeneration of CTE are poorly understood. Current well-established working models emphasize a central role for trauma-induced excessive phosphorylation and accumulation of insoluble tangles of Tau protein. In this review, we summarize recent data from preclinical animal models of CTE where a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 81 publications
0
11
0
Order By: Relevance
“…We found activation of the mTOR pathway and the inflammasome, as well as upregulation of a Tau kinase and accumulation of hyperphosphorylated, misfolded Tau, 14 months after injury (approximating 47 years in humans) (Flurkey et al, 2007). Hyperphosphorylated tau is associated with neurofibrillary tangles in AD and CTE, and inhibition of tau kinases, such as GSK3b and CDK5, has been a top research strategy to inhibit pathologic tau accumulation and prevent neurodegenerative diseases (Breen and Krishnan, 2020). Notably, IL-1R1 À/À mice did not accumulate phospho-Tau in injured cerebellum.…”
Section: Discussionmentioning
confidence: 92%
“…We found activation of the mTOR pathway and the inflammasome, as well as upregulation of a Tau kinase and accumulation of hyperphosphorylated, misfolded Tau, 14 months after injury (approximating 47 years in humans) (Flurkey et al, 2007). Hyperphosphorylated tau is associated with neurofibrillary tangles in AD and CTE, and inhibition of tau kinases, such as GSK3b and CDK5, has been a top research strategy to inhibit pathologic tau accumulation and prevent neurodegenerative diseases (Breen and Krishnan, 2020). Notably, IL-1R1 À/À mice did not accumulate phospho-Tau in injured cerebellum.…”
Section: Discussionmentioning
confidence: 92%
“…However, the preclinical understanding and development of CTE therapies remains limited by our abilities to model this disease preclinically. While some TBI models have shown acute increases in phosphorylated Tau, limited studies have demonstrated Tau inclusions and other CTE-like pathologies 80 . In most studies, researchers have relied on overexpression of human isoforms of Tau and demonstrating an increased potential to aggregate following head trauma 80 .…”
Section: Discussionmentioning
confidence: 99%
“…While some TBI models have shown acute increases in phosphorylated Tau, limited studies have demonstrated Tau inclusions and other CTE-like pathologies 80 . In most studies, researchers have relied on overexpression of human isoforms of Tau and demonstrating an increased potential to aggregate following head trauma 80 . While our finding here is exciting, more work will need to be conducted to determine the chronic effects of rTBI and the corresponding CTE-like pathologies including: the degree of TDP-43 pathology, stereological assessments of depleted neuronal populations, and solubility/isotypes of Tau inclusions.…”
Section: Discussionmentioning
confidence: 99%
“…These treatments are hypothesised to have disease-modifying effects by reducing the concentrations of toxic forms of tau in the brain or by compensating for the loss of tau function. 40 Also a series of candidate treatments, including kinase inhibitors, antibody therapy and antiinflammatory drugs are evaluated in preclinical animal models of CTE. 41 However there are some dough's that the pathogenesis of CTE is correlated solely to the repeated concussive injuries alone.…”
Section: Discussionmentioning
confidence: 99%